VERVE-102 is an experimental one-time gene-editing therapy that significantly lowered bad LDL cholesterol levels in early heart disease trials.
Goodbye Daily Statins? VERVE-102 Aims To Cut LDL Cholesterol In One Shot
Source: Times Now News
Read Full Story →
